Fate Therapeutics Inc.

1.36
0.11 (8.80%)
At close: Apr 22, 2025, 3:59 PM

Fate Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016
13.63M 63.53M 96.3M 55.85M 31.43M 10.68M 4.74M 4.11M 4.4M
n/a 161.7M 13.76M 5.85M 125.62M 87.77M 56.02M 34.36M 26.45M
13.63M -98.16M 82.54M 50M -94.19M -77.09M -51.28M -30.25M -22.05M
-210.28M -190.51M -308.39M -216.99M -128.09M -100.73M -67.09M -42.13M -31.96M
17.29M 17.19M 5.84M 1.31M 2.4M 4.33M 2.19M 559K 138K
-186.26M -160.93M -281.72M -212.15M -173.39M -98.15M -66.6M -42.95M -33.46M
-186.26M -160.93M -255.06M -206.3M -170.3M -97.71M -66.6M -42.95M -33.46M
74.17M 79.45M 84.23M 57.32M 33.9M 23.64M 15.81M 11.87M 9.91M
135M 172.6M 320.45M 215.52M 125.62M 87.77M 56.02M 34.36M 26.45M
14.74M n/a 20.82M n/a n/a n/a n/a n/a n/a
223.91M 254.04M 404.69M 272.84M 159.52M 111.41M 71.83M 46.23M 36.37M
n/a n/a 5.84M n/a n/a 1.75M 1.7M 1.27M 1.64M
n/a n/a n/a n/a n/a n/a n/a n/a n/a
223.91M 254.04M 404.69M 272.84M 159.52M 111.41M 71.83M 46.23M 36.37M
n/a n/a -26.66M -5.85M -3.09M -441K 2.19M 297K -743K
113.69M 98.41M 96.83M 94.75M 82.39M 68.19M 56.2M 41.98M 31.75M
113.69M 98.41M 96.83M 94.75M 82.39M 68.19M 56.2M 41.98M 31.75M
-1.64 -1.64 -2.63 -2.18 -2.07 -1.43 -1.19 -1.02 -1.05
-1.64 -1.64 -2.63 -2.18 -2.07 -1.43 -1.19 -1.02 -1.05
-176.58M -172.23M -294.63M -211.14M -125M -94.2M -63.7M -40.71M -30.94M
-195.54M -190.51M -308.39M -216.99M -128.09M -96.4M -64.9M -41.68M -31.82M
18.96M 18.28M 13.76M 5.85M 3.09M 2.19M 1.2M 971K 881K